Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity. 1977

Y Harano, and S Ohgaku, and H Hidaka, and K Haneda, and R Kikkawa, and Y Shigeta, and H Abe

Glucose, insulin and somatostatin infusion over 2 hours effectively suppressed endogenous secretion of insulin, glucagon and growth hormones. Steady state plasma glucose level (SSPG) which should be inversely proportional to insulin sensitivity was obtained. In 6 adult-onset non-obese untreated diabetics, mean value of insulin sensitivity indices was significantly reduced compared with normal. In 5 insulin-treated diabetics and in 5 subjects with borderline glucose tolerance including 2 obese subjects, insulin sensitivity for glucose utilization was also significantly diminished.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone
D049528 Insulin, Long-Acting Insulin formulations that contain substances that retard absorption thus extending the time period of action. Insulin, Semilente,Long-Acting Insulin,Insulin, Long Acting,Long Acting Insulin,Semilente Insulin

Related Publications

Y Harano, and S Ohgaku, and H Hidaka, and K Haneda, and R Kikkawa, and Y Shigeta, and H Abe
October 1979, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Y Harano, and S Ohgaku, and H Hidaka, and K Haneda, and R Kikkawa, and Y Shigeta, and H Abe
November 1983, Presse medicale (Paris, France : 1983),
Y Harano, and S Ohgaku, and H Hidaka, and K Haneda, and R Kikkawa, and Y Shigeta, and H Abe
November 1979, Endocrinology,
Y Harano, and S Ohgaku, and H Hidaka, and K Haneda, and R Kikkawa, and Y Shigeta, and H Abe
November 1990, Pancreas,
Y Harano, and S Ohgaku, and H Hidaka, and K Haneda, and R Kikkawa, and Y Shigeta, and H Abe
August 1981, Diabetologia,
Y Harano, and S Ohgaku, and H Hidaka, and K Haneda, and R Kikkawa, and Y Shigeta, and H Abe
July 1998, The American journal of physiology,
Y Harano, and S Ohgaku, and H Hidaka, and K Haneda, and R Kikkawa, and Y Shigeta, and H Abe
February 1996, Metabolism: clinical and experimental,
Y Harano, and S Ohgaku, and H Hidaka, and K Haneda, and R Kikkawa, and Y Shigeta, and H Abe
November 1979, Diabetologia,
Y Harano, and S Ohgaku, and H Hidaka, and K Haneda, and R Kikkawa, and Y Shigeta, and H Abe
February 1987, Japanese journal of medicine,
Y Harano, and S Ohgaku, and H Hidaka, and K Haneda, and R Kikkawa, and Y Shigeta, and H Abe
October 1978, Diabetes,
Copied contents to your clipboard!